Jackson provides a meticulously argued, extensively researched and utterly compelling critique of the current regulation of phar- maceuticals. Her account of a medicine’s journey through the regulatory system in the UK paints a frightening picture of the widespread, predatory activities of profit-seeking pharmaceutical companies and the systematic failure of law and regulation effectively to hold them to account. The UK, with its well developed and well financed pharmaceutical industry and equally well entrenched tradition of state-run health care, provides a particularly fine case study for the exploration of the tension between the ideals of medicine and the pursuit of profit and, as such, it is to be hoped that this book will gain a wide, international audience.